Neutrophil/lymphocyte ratio is related to the severity of idiopathic dilated cardiomyopathy

Scandinavian Cardiovascular Journal

Volumn 48, Issue 4, 2014, Pages 202-208

  Avci, Anil ^a   Alizade, Elnur ^a   Fidan, Serdar ^a   Yesin, Mahmut ^a   Guler, Yeliz ^a   Kargin, Ramazan ^a   Esen, Ali Metin ^a  

^a Kartal Kosuyolu Training and Research Hospital   (Turkey)

Author keywords

Echocardiography; Idiopathic dilated cardiomyopathy; Inflammation; Neutrophil lymphocyte ratio

Indexed keywords

BRAIN NATRIURETIC PEPTIDE; BIOLOGICAL MARKER;

ACUTE HEART FAILURE; ADULT; ARTICLE; BLOOD SAMPLING; CARDIOVASCULAR PARAMETERS; CONGESTIVE CARDIOMYOPATHY; DISEASE SEVERITY; ECHOCARDIOGRAPHY; FEMALE; HEART LEFT VENTRICLE EJECTION FRACTION; HEART LEFT VENTRICLE ENDDIASTOLIC VOLUME; HEMATOLOGICAL PARAMETERS; HOSPITAL ADMISSION; HUMAN; LEFT ATRIAL VOLUME INDEX; MAJOR CLINICAL STUDY; MALE; NEUTROPHIL LYMPHOCYTE RATIO; NEW YORK HEART ASSOCIATION CLASS; PREDICTION; PRIORITY JOURNAL; PROSPECTIVE STUDY; BLOOD; CARDIOMYOPATHY, DILATED; COMPLICATION; HEART ATRIUM FUNCTION; HEART FAILURE; HEART LEFT VENTRICLE FUNCTION; HEART STROKE VOLUME; LYMPHOCYTE; LYMPHOCYTE COUNT; MIDDLE AGED; MULTIVARIATE ANALYSIS; NEUTROPHIL; PATHOPHYSIOLOGY; PREDICTIVE VALUE; SEVERITY OF ILLNESS INDEX; STATISTICAL MODEL;

ADULT; ATRIAL FUNCTION, LEFT; BIOLOGICAL MARKERS; CARDIOMYOPATHY, DILATED; ECHOCARDIOGRAPHY; FEMALE; HEART FAILURE; HUMANS; LINEAR MODELS; LYMPHOCYTE COUNT; LYMPHOCYTES; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; NATRIURETIC PEPTIDE, BRAIN; NEUTROPHILS; PREDICTIVE VALUE OF TESTS; PROSPECTIVE STUDIES; SEVERITY OF ILLNESS INDEX; STROKE VOLUME; VENTRICULAR FUNCTION, LEFT;

EID: 84904613063     PISSN: 14017431     EISSN: 16512006     Source Type: Journal    
DOI: 10.3109/14017431.2014.932922     Document Type: Article

References (25)

1. Fu M. Inflammation in chronic heart failure: what is familiar, what is unfamiliar? Eur J Heart Fail. 2009; 11: 111-2.
2. Anker SD, von Haehling S. Inflammatory mediators in chronic heart failure: an overview. Heart. 2004; 90: 464-70.
3. Cooper HA, Exner DV, Waclawiw MA, Domanski MJ. White blood cell count and mortality in patients with ischemic and nonischemic left ventricular systolic dysfunction (an analysis of the Studies Of Left Ventricular Dysfunction [SOLVD]). Am J Cardiol. 1999; 84: 252-7.
4. Arruda-Olson AM, Reeder GS, Bell MR, Weston SA, Roger WL. Neutrophilia predicts death and heart failure after myo-cardial infarction: a community-based study. Circ Cardiovasc Qual Outcomes. 2009; 2: 656-62.
5. Ommen SR, Hodge DO, Rodeheffer RJ, McGregor CG, Thomson SP, Gibbons RJ. Predictive power of the relative lymphocyte concentration in patients with advanced heart failure. Circulation. 1998; 97: 19-22.
6. Han YC, Yang TH, Kim DI, Jin HY, Chung SR, Seo JS, et al. Neutrophil to lymphocyte ratio predicts long-term clinical outcomes in patients with st-segment elevation myocardial i nfarction undergoing primary percutaneous coronary i ntervention. Korean Circ J. 2013; 43: 93-9.
7. Uthamalingam S, Patvardhan EA, Subramanian S, Ahmed W, Martin W, Daley M, Capodilupo R. Utility of the neutrophil to lymphocyte ratio in predicting long-term outcomes in acute decompensated heart failure. Am J Cardiol. 2011; 107: 433-8.
8. Heymans S, Hirsch E, Anker SD, Aukrust P, Balligand JL, Cohen-Tervaert JW, et al. Inflammation as a therapeutic target in heart failure? A scientific statement from the Transla-tional Research Committee of the Heart Failure Association of the European Society of Cardiology. Eur J Heart Fail. 2009; 11: 119-29.
9. Dec GW, Fuster V. Idiopathic dilated cardiomyopathy. N Engl J Med. 1994; 331: 1564-75.
10. Wu AH. Management of patients with non-ischaemic car-diomyopathy. Heart. 2007; 93: 403-8.
11. Felker GM, Thompson RE, Hare JM, Hruban RH, Clemetson DE, Howard DL, et al. Underlying causes and long-term survival in patients with initially unexplained car-diomyopathy. N Engl J Med. 2000; 342: 1077-84.
12. Agacdiken A, Celikyurt U, Sahin T, Karauzum K, Vural A, Ural D. Neutrophil-to-lymphocyte ratio predicts response to cardiac resynchronization therapy. Med Sci Monit. 2013; 19: 373-7.
13. Lang RM, Bierig M, Devereux RB, Flachskampf FA, Foster E, Pellikka PA, et al. Recommendations for chamber quantification: a report from the American Society of Echocardiography's Guidelines and Standards Committee and the Chamber Quantification Writing Group, developed in conjunction with the European Association of Echocardi-ography, a branch of the European Society of Cardiology. J Am Soc Echocardiogr. 2005; 18: 1440-63.
14. Nagueh SF, Appleton CP, Gillebert TC, Marino PN, Oh JK, Smiseth OA, et al. Recommendations for the evaluation of left ventricular diastolic function by echocardiography. Eur J Echocardiogr. 2009; 10: 165-93.
15. Vahanian A, Baumgartner H, Bax J, Butchart E, Dion R, Filippatos G, et al. Guidelines on the management of valvular heart disease: the Task Force on the Management of Valvular Heart Disease of the European Society of Cardiology. Eur Heart J. 2007; 28: 230-68.
16. Horton KD, Meece RW, Hill JC. Assessment of the right ventricle by echocardiography: a primer for cardiac sonogra-phers. J Am Soc Echocardiogr. 2009; 22: 776-92.
17. Acanfora D, Gheorghiade M, Trojano L, Furgi G, Pasini E, Picone C, et al. Relative lymphocyte count: a prognostic indicator of mortality in elderly patients with congestive heart failure. Am Heart J. 2001; 142: 167-73.
18. Shantsila E, Bialiuk N, Navitski D, Pyrochkin A, Gill PS, Pyrochkin V, et al. Blood leukocytes in heart failure with preserved ejection fraction: impact on prognosis. Int J Car-diol. 2012; 155: 337-8.
19. Solomon SD, Anavekar N, Skali H, McMurry JJ, Swedberg K, Yusuf S, et al. Influence of ejection fraction on cardiovascular outcomes in a broad spectrum of heart failure patients. Circulation. 2005; 112: 3738-44.
20. Ahmed A. A propensity matched study of New York Heart Association class and natural history end points in heart failure. Am J Cardiol. 2007; 99: 549-53.
21. Murray DR, Freeman GL. Proinflammatory cytokines: predictors of a failing heart? Circulation. 2003; 107: 1460-2.
22. Fruhwald FM, Fahrleitner A, Watzinger N, Fruhwald S, Dobnig H, Schumacher M, et al. Natriuretic peptides in patients with diastolic dysfunction due to idiopathic dilated cardiomyopathy. Eur Heart J. 1999; 20: 1415-23.
23. Popescu BA, Popescu AC, Antonini-Canterin F, Rubin D, Cappelletti P, Piazza R, et al. Prognostic role of left atrial volume in elderly patients with symptomatic stable chronic heart failure: comparison with left ventricular diastolic dysfunction and B-type natriuretic peptide. Echocardiography. 2007; 24: 1035-43.
24. Sciarretta S, Paneni F, Palano F, Chin D, Tocci G, Rubattu S, et al. Role of the renin-angiotensin-aldosterone system and inflammatory processes in the development and progression of diastolic dysfunction. Clin Sci (Lond). 2009; 116: 467-77.
25. Isaac DL. Biomarkers in heart failure management. Curr Opin Cardiol. 2008; 23: 127-33.